|
1
|
Devic E: Subacute myelitis complicated by
optic neuritis. Bull Med. 8:1033–1034. 1894.(In French).
|
|
2
|
Lennon VA, Wingerchuk DM, Kryzer TJ,
Pittock SJ, Lucchinetti CF, Fujihara K, Nakashima I and Weinshenker
BG: A serum autoantibody marker of neuromyelitis optica:
Distinction from multiple sclerosis. Lancet. 364:2106–2112. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Lennon VA, Kryzer TJ, Pittock SJ, Verkman
AS and Hinson SR: IgG marker of optic-spinal multiple sclerosis
binds to the aquaporin-4 water channel. J Exp Med. 202:473–477.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Kira J: Neuromyelitis optica and
opticospinal multiple sclerosis: Mechanisms and pathogenesis.
Pathophysiology. 18:69–79. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Lim BC, Hwang H, Kim KJ, Hwang YS, Cheon
JE, Kim IO, Kim HJ and Chae JH: Relapsing demyelinating CNS disease
in a Korean pediatric population: Multiple sclerosis versus
neuromyelitis optica. Mult Scler. 17:67–73. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Wingerchuk DM, Lennon VA, Pittock SJ,
Lucchinetti CF and Weinshenker BG: Revised diagnostic criteria for
neuromyelitis optica. Neurology. 66:1485–1489. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Polman CH, Reingold SC, Edan G, Filippi M,
Hartung HP, Kappos L, Lublin FD, Metz LM, McFarland HF, O'Connor
PW, et al: Diagnostic criteria for multiple sclerosis: 2005
revisions to the ‘McDonald Criteria’. Ann Neurol. 58:840–846. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Takahashi T, Fujihara K, Nakashima I, Misu
T, Miyazawa I, Nakamura M, Watanabe S, Ishii N and Itoyama Y:
Establishment of a new sensitive assay for anti-human aquaporin-4
antibody in neuromyelitis optica. Tohoku J Exp Med. 210:307–313.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Hiroaki Y, Tani K, Kamegawa A, Gyobu N,
Nishikawa K, Suzuki H, Walz T, Sasaki S, Mitsuoka K, Kimura K, et
al: Implications of the aquaporin-4 structure on array formation
and cell adhesion. J Mol Biol. 355:628–639. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Amiry-Moghaddam M, Xue R, Haug FM, Neely
JD, Bhardwaj A, Agre P, Adams ME, Froehner SC, Mori S and Ottersen
OP: Alpha-syntrophin deletion removes the perivascular but not
endothelial pool of aquaporin-4 at the blood-brain barrier and
delays the development of brain edema in an experimental model of
acute hyponatremia. FASEB J. 18:542–544. 2004.PubMed/NCBI
|
|
11
|
Cavazzin C, Ferrari D, Facchetti F,
Russignan A, Vescovi AL, La Porta CA and Gritti A: Unique
expression and localization of aquaporin-4 and aquaporin-9 in
murine and human neural stem cells and in their glial progeny.
Glia. 53:167–181. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Tomás-Camardiel M, Venero JL, Herrera AJ,
De Pablos RM, Pintor-Toro JA, Machado A and Cano J: Blood-brain
barrier disruption highly induces aquaporin-4 mRNA and protein in
perivascular and parenchymal astrocytes: Protective effect by
estradiol treatment in ovariectomized animals. J Neurosci Res.
80:235–246. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Niu CH and Zhang XH: The research progress
of pathogenesis and treatment strategy of neuromyelitis optica.
Chin J Neuroimmunol Neurol. 20:208–211. 2013.(In Chinese).
|
|
14
|
Fujihara K: Neuromyelitis optica and
astrocytic damage in its pathogenesis. J Neurol Sci. 306:183–187.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Pittock SJ, Weinshenker BG, Lucchinetti
CF, Wingerchuk DM, Corboy JR and Lennon VA: Neuromyelitis optica
brain lesions localized at sites of high aquaporin 4 expression.
Arch Neurol. 63:964–968. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Pittock SJ, Lennon VA, Krecke K,
Wingerchuk DM, Lucchinetti CF and Weinshenker BG: Brain
abnormalities in neuromyelitis optica. Arch Neurol. 63:390–396.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Wingerchuk DM: Neuromyelitis optica: New
findings on pathogenesis. Int Rev Neurobiol. 79:665–688. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Dean G, Yeo TW, Goris A, Taylor CJ,
Goodman RS, Elian M, Galea-Debono A, Aquilina A, Felice A, Vella M,
et al: HLA-DRB1 and multiple sclerosis in Malta. Neurology.
70:101–105. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
McElroy JP, Cree BA, Caillier SJ,
Gregersen PK, Herbert J, Khan OA, Freudenberg J, Lee A, Bridges SL
Jr, Hauser SL, et al: Refining the association of MHC with multiple
sclerosis in African Americans. Hum Mol Genet. 19:3080–3088. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Sorani MD, Zador Z, Hurowitz E, Yan D,
Giacomini KM and Manley GT: Novel variants in human Aquaporin-4
reduce cellular water permeability. Hum Mol Genet. 17:2379–2389.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Kleffner I, Bungeroth M, Schiffbauer H,
Schäbitz WR, Ringelstein EB and Kuhlenbäumer G: The role of
aquaporin-4 polymorphisms in the development of brain edema after
middle cerebral artery occlusion. Stroke. 39:1333–1335. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Mai WH, Hu XQ, Long YM, Lu ZQ, Peng FH and
Wang YG: Associations of aquaporin-4 promoter polymorphism to
multiple sclerosis and neuromyelitis optica in southern Chinese
population. Chin J Neurol. 45:312–317. 2012.
|
|
23
|
Matiello M, Schaefer-Klein JL, Hebrink DD,
Kingsbury DJ, Atkinson EJ and Weinshenker BG NMO Genetics
Collaborators: Genetic analysis of aquaporin-4 in neuromyelitis
optica. Neurology. 77:1149–1155. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Stevanin G, Ruberg M and Brice A: Recent
advances in the genetics of spastic paraplegias. Curr Neurol
Neurosci Rep. 8:198–210. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Waters P, Jarius S, Littleton E, Leite MI,
Jacob S, Gray B, Geraldes R, Vale T, Jacob A, Palace J, et al:
Aquaporin-4 antibodies in neuromyelitis optica and longitudinally
extensive transverse myelitis. Arch Neurol. 65:913–919. 2008.
View Article : Google Scholar : PubMed/NCBI
|
